| |
| |
|
| Insider
Information: |
Rovaldi Christopher |
| Relationship: |
Chief Operating Officer |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
25,858 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$4,622,118 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
25,858 |
|
|
| Total
Value |
$4,622,118 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Acceleron Pharma Inc |
XLRN |
SVP, Program Mgmt and ... |
2018-04-03 |
25,858 |
|
0 |
Premium* |
|
|
Keros Therapeutics, Inc. |
KROS |
Chief Operating Officer |
2022-04-06 |
0 |
2022-04-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
12 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| KROS |
Keros Therapeutics, Inc. |
Chief Operating Officer |
• – – |
2022-04-06 |
4 |
AS |
$65.00 |
$112,320 |
D/D |
(1,728) |
0 |
0 |
- |
|
| KROS |
Keros Therapeutics, Inc. |
Chief Operating Officer |
• – – |
2022-04-06 |
4 |
OE |
$16.00 |
$27,648 |
D/D |
1,728 |
1,728 |
0 |
- |
|
| KROS |
Keros Therapeutics, Inc. |
Chief Operating Officer |
• – – |
2022-04-01 |
4 |
AS |
$54.34 |
$49,675 |
D/D |
(864) |
0 |
0 |
- |
|
| KROS |
Keros Therapeutics, Inc. |
Chief Operating Officer |
• – – |
2022-04-01 |
4 |
OE |
$16.00 |
$13,824 |
D/D |
864 |
864 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP, Program Mgmt and Ops |
• – – |
2018-04-03 |
4 |
AS |
$38.27 |
$134,395 |
D/D |
(3,500) |
25,858 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP, Program Mgmt and Ops |
• – – |
2018-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
4,063 |
28,764 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP, Program Mgmt and Ops |
• – – |
2018-01-12 |
4 |
AS |
$45.00 |
$495,000 |
D/D |
(11,000) |
24,701 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP, Program Mgmt and Ops |
• – – |
2018-01-12 |
4 |
OE |
$24.11 |
$265,210 |
D/D |
11,000 |
35,701 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP, Program Mgmt and Ops |
• – – |
2018-01-03 |
4 |
AS |
$42.45 |
$35,361 |
D/D |
(833) |
24,701 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP, Program Mgmt and Ops |
• – – |
2018-01-02 |
4 |
AS |
$42.41 |
$60,774 |
D/D |
(1,433) |
25,534 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP, Program Mgmt and Ops |
• – – |
2017-09-12 |
4 |
AS |
$38.32 |
$537,786 |
D/D |
(14,000) |
26,967 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP, Program Mgmt and OpsOffic |
• – – |
2017-04-28 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
40,967 |
|
- |
|
12 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
